Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer

Purpose: Colitis-associated colorectal cancer (CAC) poses substantial challenges for effective treatment. Currently, there is a considerable need for the development of orally bioavailable dosage forms that enable the safe and effective delivery of therapeutic drugs to local diseased lesions in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Weidong, Xie, Binbin, Li, Yiran, Shi, Linlin, Wan, Jianqin, Chen, Xiaona, Wang, Hangxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831307/
https://www.ncbi.nlm.nih.gov/pubmed/31695780
http://dx.doi.org/10.7150/thno.38081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831307/
https://www.ncbi.nlm.nih.gov/pubmed/31695780
http://dx.doi.org/10.7150/thno.38081

Ejemplares similares